news
-
ASTRO ANNUAL MEETING 2020
- September 22, 2020
The American SocieTy for Radiation & Oncology (ASTRO) Annual Meeting
October 25-28, 2020
Miami Beach Convention Center, Miami Beach, Florida, USA
Booth # 6317 -
[Article] A head-to-head Comparison between Two Commercial Software Packages for Hybrid Dosimetry after Peptide Receptor Radionuclide Therapy
- September 18, 2020
Daphne M. V. Huizing, Steffie M. B. Peters, Michelle W. J. Versleijen, Esther Martens, Marcel Verheij et al.
EJNMMI Physics (2020) 7:36 https://doi.org/10.1186/s40658-020-00308-9 -
[Abstract] Evaluation of a Novel EPID Based Dosimetry System for Verification of VMAT QA in Comparison with Traditional 3D Detector Quality Assurance
- September 8, 2020
R Varadhan, S Way, C Overbeck, M Bedoya, A Jahagirdar, R Malmin, R Malmin
AAPM ePoster Library. Varadhan R. 07/12/20; 302323; PO-GeP-T-399 Topic: Photon External Beam Therapy
Presented at AAPM Virtual Congress 2020 -
[Customer Testimonial] EPIbeam pretreatment quality assurance saves time, releases resources and enhances flexibility at the Léon Bérard Center
- September 8, 2020
Since it began using EPIbeam pretreatment quality assurance (QA) in March 2019, the Léon Bérard Center in Lyon, France, has achieved a 65% reduction in machine time dedicated to QA, allowing more patients to receive valuable SBRT treatments every week.
-
EANM VIRTUAL CONGRESS 2020
- August 15, 2020
Annual Congress of the European Association of Nuclear Medicine (EANM)
October 21-25, 2020
Vienna, Austria -
Joint AAPM-COMP Virtual Meeting
- June 12, 2020
Joint AAPM-COMP Annual Meeting (The American Association of Physicists in Medicine)
July 12-16, 2020 -
DOSIMETRY WINTER SCHOOL
- January 27, 2020
Winter School “Dosimetry-Guided Treatment Planning for Radionuclide Therapy”.
[TBA], 2020
Bern, Switzerland -
Season’s Greetings 2020 from DOSIsoft
- December 19, 2019
Merry Christmas & Happy New Year 2020! We thank you for all the support & trust you bring to improve cancer treatment quality and patient safety!
-
[AuntMinnie.com] DOSIsoft gets FDA nod for MU2net software
- November 11, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.
-
DOSIsoft MU2net is FDA 510(k) Cleared for Patient QA – Secondary Dose Calculation
- November 7, 2019
DOSIsoft, leading provider of patient-specific software solutions for Radiation Oncology and Nuclear Medicine, is pleased to announce that on October 24th, 2019, it received 510(k) clearance from the US Food and Drug Administration (FDA), to market MU2net, software dedicated to Independent Secondary Dose Calculation for Patient Quality Assurance (QA).